Seeing Is Believing
Currently out of the existing stock ratings of Trung Huynh, 42 are a HOLD (41.18%), 55 are a BUY (53.92%), 5 are a SELL (4.9%).
Analyst Trung Huynh, currently employed at RBC, carries an average stock price target met ratio of 68.52% that have a potential upside of 12.52% achieved within 240 days.
Trung Huynh’s has documented 202 price targets and ratings displayed on 18 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on BMY, Bristol-Myers Squibb Company at 31-Jul-2026.
Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 4/28/2023. The price target of $420 was fulfilled within 5 days with a profit of $32.83 (8.48%) receiving and performance score of 16.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 05-Aug-2021
$10
$2.13 (27.06%)
$10.3
7 months 28 days ago
(08-Dec-2025)
5/6 (83.33%)
$1.02 (11.36%)
77
Buy Since 05-Apr-2024
$11.8
2 years 4 months ago
(05-Apr-2024)
2/4 (50%)
$2.84 (31.70%)
46
Hold Since 10-Nov-2021
2 years 4 months 24 days ago
(12-Mar-2024)
0/2 (0%)
$10.82 (88.04%)
Hold Since 24-Aug-2023
$14.64
$6.43 (78.32%)
$31.9
2 years 11 months 12 days ago
(24-Aug-2023)
0/5 (0%)
$5.07 (52.98%)
Buy Since 10-Jun-2020
$27.53
$19.32 (235.32%)
3 years 3 months ago
(05-May-2023)
0/11 (0%)
$20.21 (276.09%)
Which stock is Trung Huynh is most bullish on?
Which stock is Trung Huynh is most reserved on?
What Year was the first public recommendation made by Trung Huynh?